Royal Bank Of Canada Aptorum Group LTD Transaction History

Royal Bank Of Canada

  • $425 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.42 - $11.7 $3 - $93
8 New
8 $0
Q1 2022

May 16, 2022
SELL
$1.22 - $2.28 $50 - $93
-41 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$1.5 - $2.64 $61 - $108
41 New
41 $0

Others Institutions Holding APM

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Aptorum Group Ltd

APM Quotes by TradingView
  • Ticker APM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,265,500
  • Market Cap $28.1M
  • Description
  • Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-...
More about APM
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email